RG
NVS icon

Redmile Group’s Novartis NVS Stock Holding History

Redmile Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-439,800
Closed -$38.4M – 87
2020
Q2 		$38.4M Sell
439,800
-213,800
-33% -$18.5M 0.71% 42
2020
Q1 		$53.9M Buy
653,600
+80,500
+14% +$7.18M 1.51% 22
2019
Q4 		$54.3M Buy
+573,100
New +$51.4M 1.3% 25

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Redmile Group's NVS Position: Q3 2020 in Review

Redmile Group sold out of Novartis (NVS) in Q3 2020, closing a stake of 439,800 shares — an estimated $38.4M sold.

Redmile Group first reported a position in NVS in Q4 2019 and held it in 3 quarters. The position peaked at $54.3M in Q4 2019. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • Redmile Group reported no remaining Novartis position as of Q3 2020 after selling out during the quarter.
  • Redmile Group sold 439,800 Novartis shares in Q3 2020, an estimated $38.4M.
  • Redmile Group first reported a position in Novartis in Q4 2019 and held it in 3 quarters.
  • Redmile Group's Novartis position peaked at $54.3M in Q4 2019.
  • 1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Redmile Group's 13F filing for Q3 2020, filed 16 Nov 2020.